Sun Young Kim Selected Research

Drug Therapy (Chemotherapy)

5/2022	Immune Profile of BRAF-Mutated Metastatic Colorectal Tumors with Good Prognosis after Palliative Chemotherapy.
1/2022	The impact of systematic assessment for adverse events on unscheduled hospital utilization in patients receiving neoadjuvant or adjuvant chemotherapy: A retrospective multicenter study.
1/2022	Phase II study of durvalumab monotherapy in patients with previously treated microsatellite instability-high/mismatch repair-deficient or POLE-mutated metastatic or unresectable colorectal cancer.
4/2021	Incidence and disease course of new-onset diabetes mellitus in breast and colorectal cancer patients undergoing chemotherapy: A prospective multicenter cohort study.
1/2021	Prevalence and Predictive Factors for Upfront Dose Reduction of the First Cycle of First-Line Chemotherapy in Older Adults with Metastatic Solid Cancer: Korean Cancer Study Group (KCSG) Multicenter Study.
1/2021	Proton Pump Inhibitor Use and the Efficacy of Chemotherapy in Metastatic Colorectal Cancer: A Post Hoc Analysis of a Randomized Phase III Trial (AXEPT).
1/2021	Effectiveness of Combining Bevacizumab With First-Line Chemotherapy Regimens for Metastatic Colorectal Cancer in Real-World Practice.
1/2019	Association of CHFR Promoter Methylation with Treatment Outcomes of Irinotecan-Based Chemotherapy in Metastatic Colorectal Cancer.
1/2019	Sex-Dependent Adverse Drug Reactions to 5-Fluorouracil in Colorectal Cancer.
5/2018	Nomograms predicting survival of patients with unresectable or metastatic gastric cancer who receive combination cytotoxic chemotherapy as first-line treatment.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sun Young Kim Research Topics

Disease

107	Neoplasms (Cancer) 10/2022 - 04/2005
61	Colorectal Neoplasms (Colorectal Cancer) 11/2022 - 02/2009
48	Rectal Neoplasms (Rectal Cancer) 01/2021 - 03/2010
22	Neoplasm Metastasis (Metastasis) 07/2022 - 02/2002
16	Colonic Neoplasms (Colon Cancer) 11/2022 - 02/2009
11	Stomach Neoplasms (Stomach Cancer) 01/2019 - 10/2005
10	Inflammation (Inflammations) 01/2020 - 08/2010
10	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2017 - 01/2011
9	Adenocarcinoma 01/2021 - 10/2005
6	Infections 03/2022 - 10/2011
5	Disease Progression 01/2022 - 11/2012
5	Breast Neoplasms (Breast Cancer) 11/2018 - 01/2008
5	Carcinoma (Carcinomatosis) 07/2017 - 06/2007
4	Nausea 10/2022 - 02/2010
4	Microsatellite Instability 01/2022 - 05/2017
4	Type 2 Diabetes Mellitus (MODY) 04/2021 - 05/2007
4	Hypoxia (Hypoxemia) 07/2015 - 07/2009
3	Vomiting 10/2022 - 02/2010
3	Fatigue 10/2022 - 07/2010
3	Tuberculosis (Tuberculoses) 03/2022 - 02/2010
3	Thrombocytopenia (Thrombopenia) 01/2021 - 10/2014
3	Sepsis (Septicemia) 12/2020 - 01/2018
3	Hematologic Neoplasms (Hematological Malignancy) 10/2018 - 04/2006
3	Guillain-Barre Syndrome 07/2018 - 03/2013
3	Margins of Excision 04/2018 - 07/2010
3	Pathologic Complete Response 03/2017 - 02/2009
3	Carcinogenesis 10/2016 - 05/2014
3	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2016 - 01/2007
3	Neutropenia 10/2014 - 05/2013
3	Necrosis 04/2014 - 09/2009
2	Diarrhea 10/2022 - 04/2014
2	Diabetes Mellitus 04/2021 - 02/2013
2	Colitis 10/2020 - 09/2017
2	Non-alcoholic Fatty Liver Disease 11/2019 - 11/2015
2	Glaucoma 11/2019 - 07/2012
2	Melanoma (Melanoma, Malignant) 06/2019 - 01/2018
2	Thrombosis (Thrombus) 08/2018 - 10/2011
2	Peripheral Nervous System Diseases (PNS Diseases) 07/2018 - 01/2018
2	Lung Neoplasms (Lung Cancer) 01/2018 - 04/2017
2	Hepatocellular Carcinoma (Hepatoma) 01/2018 - 10/2016
2	Sarcoma (Soft Tissue Sarcoma) 01/2018 - 06/2016
2	Cataract (Cataracts) 07/2017 - 02/2013

Drug/Important Bio-Agent (IBA)

21	Oxaliplatin (Eloxatin)FDA LinkGeneric 11/2022 - 06/2009
15	Irinotecan (Camptosar)FDA LinkGeneric 01/2021 - 01/2007
15	Capecitabine (Xeloda)FDA Link 01/2021 - 02/2008
12	Biomarkers (Surrogate Marker)IBA 10/2022 - 11/2013
12	Proteins (Proteins, Gene)FDA Link 01/2022 - 06/2007
11	Pharmaceutical PreparationsIBA 06/2022 - 08/2010
11	Cetuximab (Erbitux)FDA Link 01/2022 - 06/2009
9	Biological ProductsIBA 01/2022 - 08/2011
8	Fluorouracil (Carac)FDA LinkGeneric 01/2021 - 12/2012
8	Carcinoembryonic AntigenIBA 02/2016 - 07/2010
7	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021 - 04/2008
7	Bevacizumab (Avastin)FDA Link 01/2021 - 07/2009
7	Leucovorin (Folinic Acid)FDA Link 01/2021 - 04/2013
7	ErbB Receptors (EGF Receptor)IBA 01/2018 - 06/2009
6	Messenger RNA (mRNA)IBA 12/2019 - 09/2007
6	Cisplatin (Platino)FDA LinkGeneric 01/2016 - 01/2007
5	SteroidsIBA 03/2022 - 02/2013
5	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 03/2012
5	Tyrosine Kinase InhibitorsIBA 12/2019 - 03/2012
4	Immunoglobulin G (IgG)IBA 01/2021 - 09/2007
4	Therapeutic UsesIBA 12/2020 - 02/2015
4	AntigensIBA 01/2018 - 02/2010
3	Calcibiotic Root Canal SealerIBA 11/2022 - 11/2013
3	Lactic Acid (Lactate)FDA LinkGeneric 10/2022 - 07/2016
3	RNA (Ribonucleic Acid)IBA 01/2022 - 02/2017
3	Trastuzumab (Herceptin)FDA Link 01/2019 - 01/2008
3	Gefitinib (Iressa)FDA Link 11/2018 - 02/2014
3	Phosphotransferases (Kinase)IBA 01/2018 - 08/2010
3	Epithelial Cell Adhesion MoleculeIBA 07/2017 - 10/2014
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2016 - 11/2010
3	Capsules (Microcapsules)IBA 10/2013 - 09/2012
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2022 - 09/2009
2	Gonadal Steroid Hormones (Sex Hormones)IBA 01/2022 - 06/2021
2	Estrogens (Estrogen)FDA Link 01/2022 - 05/2013
2	CKD-497IBA 01/2021 - 07/2020
2	AcidsIBA 12/2020 - 05/2014
2	Dextran SulfateIBA 10/2020 - 09/2017
2	Transcription Factors (Transcription Factor)IBA 01/2020 - 05/2014
2	regorafenibIBA 12/2019 - 07/2019
2	AntibodiesIBA 07/2018 - 04/2014
2	MucinsIBA 05/2018 - 01/2012
2	Panitumumab (Vectibix)FDA Link 01/2018 - 11/2016
2	Sorafenib (BAY 43-9006)FDA Link 01/2018 - 10/2016
2	AZD4547IBA 08/2017 - 05/2017
2	Adenosine Triphosphate (ATP)IBA 03/2017 - 06/2013

Therapy/Procedure

42	Drug Therapy (Chemotherapy) 05/2022 - 02/2009
41	Therapeutics 11/2022 - 01/2003
40	Chemoradiotherapy 01/2021 - 03/2010
10	Radiotherapy 07/2022 - 06/2010
8	Adjuvant Chemotherapy 01/2022 - 07/2010
6	Neoadjuvant Therapy 01/2021 - 07/2010
4	Palliative Care (Palliative Therapy) 01/2022 - 07/2010
3	Salvage Therapy 11/2017 - 11/2010
3	Metastasectomy 06/2013 - 02/2009
2	Radiofrequency Ablation 07/2022 - 07/2013
2	Resuscitation 04/2020 - 01/2018
2	Oral Administration 09/2017 - 01/2017
2	Intraocular Lenses (Intraocular Lens) 07/2017 - 02/2013